In the press.

Third-party coverage of Nome — articles, podcasts, investor blogs, and commentary.

Forbes · Article

The ROI of AI Medicine

Oct 14, 2025
Becker's Healthcare · Podcast

Using AI to Power Custom Treatments for Rare Diseases
Benzinga · Commentary

The End of the Orphan Era: Why Personalized Medicine Is Finally Scalable
Twelve Below · Investor Blog

Nome Raises $2.7M to Build AI-Powered Drug Development for Rare Diseases

Press Inquiries

Working on a story about personalized therapeutics?